Company intelligence / Profile preview

SEI Ventures

Ownership: Private
Development stage: Other

Overview

SEI Ventures is a corporate venture capital program associated with SEI that invests in early-stage companies pursuing strategic, emerging, and potentially disruptive technologies. Available public information indicates it functions as an investor rather than as a therapeutics, diagnostics, medical device, or healthcare operating company. The entity appears to focus on venture investing and startup support rather than internal drug development or commercialization. Based on the available evidence, it should not be classified as a life science, biotech, pharma, or healthcare company.

Industry: Investors

Beyond the preview

Go deeper on SEI Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SEI Ventures.

Explore the full profile